Notably, a higher molecular weight band—detected with anti-Cat-315 and -PTPRZ (Santa Cruz) antibodies—emerged with GlcAT-P expression, similar to that observed in brain lysates from xenograft glioma model mice (Fig. 3A). The gene discussed is PTPRZ1; the disease is central nervous system cancer.